AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Moderna, Inc. Director's Dealing 2020

Jun 4, 2020

Director's Dealing

Opens in your device viewer

Issuer: Moderna, Inc. (MRNA)
CIK: 0001682852
Period of Report: 2020-05-19

Reporting Person: Zaks Tal Zvi (Chief Medical Officer)

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-05-19	Common Stock	S	125044	$78.16	Disposed	0	Direct

F1: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 13, 2020.